Thermo Fisher to Buy Qiagen in $11.5B Deal

U.S. laboratory equipment maker Thermo Fisher Scientific has reached an agreement to buy genetic testing supply company Qiagen in an $11.5 billion deal. At 39 euros per share (about $43.42), the cash offer represents a premium of approximately 23% to the closing price of Qiagen on March 2, the companies said. It includes the assumption […]